Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2019 Q2- Text added to 2019 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
adult, aggressive, chemoimmunotherapy, confirmed, cutoff, DLT, ESMO, front, harbor, HNSCC, hydrogen, intratumoral, invasion, led, malaise, mechanistic, month, oxidase, oxygen, peroxide, Pharmacodynamic, phenylalanine, PK, preceding, proportion, reactive, RECIST, responder, ROS, Simon, SITC, spread, stimulate, Topline, version, vivo
Valuein 2019 Q2 filing- Value in 2019 Q3 filing
Original filings
Filing view